The use of 13C labeling to enhance the sensitivity of 13C solid-state CPMAS NMR to study polymorphism in low dose solid formulations.
暂无分享,去创建一个
[1] P. Gao. Determination of the Composition of Delavirdine Mesylate Polymorph and Pseudopolymorph Mixtures Using 13C CP/MAS NMR , 1996, Pharmaceutical Research.
[2] D. Bugay. Solid-State Nuclear Magnetic Resonance Spectroscopy: Theory and Pharmaceutical Applications , 1993, Pharmaceutical Research.
[3] S. Byrn,et al. Solid-State Nuclear Magnetic Resonance (NMR) Spectra of Pharmaceutical Dosage Forms , 1993, Pharmaceutical Research.
[4] S. Byrn,et al. Solid-state nuclear magnetic resonance spectroscopy--pharmaceutical applications. , 2003, Journal of pharmaceutical sciences.
[5] G. Bruni,et al. Solid-state characterization of a novel chemotherapeutic drug. , 2003, Journal of pharmaceutical sciences.
[6] D. Bugay. Characterization of the solid-state: spectroscopic techniques. , 2001, Advanced drug delivery reviews.
[7] G A Stephenson,et al. Characterization of the solid state: quantitative issues. , 2001, Advanced drug delivery reviews.
[8] E. Munson,et al. Two-Dimensional High-Speed CP/MAS NMR Spectroscopy of Polymorphs. 1. Uniformly 13C-Labeled Aspartame , 1999 .
[9] T. Threlfall. Analysis of organic polymorphs. A review , 1996 .
[10] L. Frydman,et al. Solid State NMR of Drugs: Soluble Aspirin , 1987 .
[11] N. Jagannathan. High-resolution solid-state carbon-13 nuclear magnetic resonance study of acetaminophen: a common analgesic drug , 1987 .
[12] D. Grant,et al. Solid‐state 13C NMR study of drugs: Aspirin , 1986 .
[13] S. Byrn. Solid state chemistry of drugs , 1982 .